Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    ES07 - Pleural Effusion in a Cancer Patient

    • 15:30 - 16:30
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Diagnostics and Interventional Pulmonology
    • +

      ES07.01 - Radiological Evaluation of Pleural Effusion in a Cancer Patient

      15:30 - 15:45  |  Presenter: Yeun-Chung Chang

      • Abstract

      Loading...

    • +

      ES07.02 - Role of Pleural Fluid Molecular Markers and PD-L1 Testing

      15:45 - 16:00  |  Presenter: Zoltan Lohinai

      • Abstract

      Loading...

    • +

      ES07.03 - Malignant Pleural Effusion: Patient Presentation and Diagnostic Pathway

      16:00 - 16:15  |  Presenter: Laura McNaughton

      • Abstract

      No abstract available for this presentation

    • +

      ES07.04 - Chemical Pleurodesis, Indwelling Pleural Catheter or Both for Malignant Pleural Effusion

      16:15 - 16:30  |  Presenter: Pyng Lee

      • Abstract

      No abstract available for this presentation

  • +

    MA03 - New and Revisited Prognostic Factors in Early Stage Lung Cancer

    • 15:30 - 16:30
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Early Stage/Localized Disease
    • +

      MA03.01 - Chair

      15:30 - 15:30  |  Presenter: Peter Licht

      • Abstract

      No abstract available for this presentation

    • +

      MA03.02 - Chair

      15:30 - 15:30  |  Presenter: Eric Lim

      • Abstract

      No abstract available for this presentation

    • +

      MA03.03 - Subsolid Lesions Exceeding 3cm: Do the Ground-Glass Opacity Components Still Matter?

      15:30 - 15:35  |  Presenter: fan fan Fan

      • Abstract

      Loading...

    • +

      MA03.04 - Gender-specific Radiomics Models for Predicting Recurrence in Early Stage (Stage I, II) Non-Small Cell Lung Cancer (ES-NSCLC) Patients

      15:35 - 15:40  |  Presenter: Pranjal Vaidya

      • Abstract

      Loading...

    • +

      MA03.05 - Hierarchy of Adverse-Prognosis Quality Markers after Curative-Intent Resection of Non-Small Cell Lung Cancer (NSCLC)

      15:40 - 15:45  |  Presenter: Ray Uyiosa Osarogiagbon

      • Abstract

      Loading...

    • +

      MA03.06 - Health-Related Quality of Life in Lung Cancer Patients Undergoing Thoracic Surgery

      15:45 - 15:50  |  Presenter: Eagan Peters

      • Abstract

      Loading...

    • +

      MA03.07 - Discussant

      15:50 - 15:55  |  Presenter: Wentao Fang

      • Abstract

      No abstract available for this presentation

    • +

      MA03.08 - Impact of COVID-19 Pandemic in the Diagnosis and Prognosis of Lung Cancer

      15:55 - 16:00  |  Presenter: Roxana Reyes

      • Abstract

      Loading...

    • +

      MA03.09 - Can Clinical Variables be used to Provide Better Follow up in Stereotactic Ablative Radiotherapy (SABR) Treated Lung Cancers?

      16:00 - 16:05  |  Presenter: Nathaniel Luke Hatton

      • Abstract

      Loading...

    • +

      MA03.10 - Venous Thromboembolism in Lung Cancer Patients: A Population-Based Study

      16:05 - 16:10  |  Presenter: Gilly Akhtar-Danesh

      • Abstract

      Loading...

    • +

      MA03.11 - Cognitive Bias in Lung Cancer Surgery: The Left Digit Effect

      16:10 - 16:15  |  Presenter: Chi-fu Jeffrey Yang

      • Abstract

      Loading...

    • +

      MA03.12 - Discussant

      16:15 - 16:20  |  Presenter: Jay M. Lee

      • Abstract

      No abstract available for this presentation

    • +

      MA03.13 - Live Q&A

      16:20 - 16:30

      • Abstract

      No abstract available for this presentation

  • +

    OA05 - Value and Quality in Lung Cancer

    • 15:30 - 16:30
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Health Services Research/Health Economics
    • +

      OA05.01 - Chair

      15:30 - 15:30  |  Presenter: Narjust Duma

      • Abstract

      No abstract available for this presentation

    • +

      OA05.02 - Chair

      15:30 - 15:30  |  Presenter: CS Pramesh

      • Abstract

      No abstract available for this presentation

    • +

      OA05.03 - Real-World Global Data on Targeting Epidermal Growth Factor Receptor in Stage III Non-Small Cell Lung Cancer: The Results of the KINDLE Study

      15:30 - 15:40  |  Presenter: Abdul Rahman Jazieh

      • Abstract

      Loading...

    • +

      OA05.04 - Clinical and Economic Impact of the Current Testing Scenario for ALK Rearrangements in Spain Compared to a Hypothetical No-Testing Scenario.

      15:40 - 15:50  |  Presenter: Ana Laura Ortega Granados

      • Abstract

      Loading...

    • +

      OA05.05 - Economic Impact of Next-Generation Sequencing (NGS) vs. Single-gene Testing Strategies to Detect Genomic Alterations (GAs) in mNSCLC in Asia

      15:50 - 16:00  |  Presenter: Herbert H Loong

      • Abstract

      Loading...

    • +

      OA05.06 - Lessons Learned from the Victorian Lung Cancer Registry: Opportunities for Quality Improvement in Lung Cancer Management and Outcomes

      16:00 - 16:10  |  Presenter: Rob G Stirling

      • Abstract

      Loading...

    • +

      OA05.07 - Discussant

      16:10 - 16:20  |  Presenter: Doreen A Ezeife

      • Abstract

      No abstract available for this presentation

    • +

      OA05.08 - Live Q&A

      16:20 - 16:30

      • Abstract

      No abstract available for this presentation

  • +

    ES08 - The Solitary Pulmonary Nodule

    • 16:45 - 17:45
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Diagnostics and Interventional Pulmonology
    • +

      ES08.01 - Chair

      16:45 - 16:45  |  Presenter: Haja Mohideen Salahudeen Mohamed

      • Abstract

      No abstract available for this presentation

    • +

      ES08.02 - Chair

      16:45 - 16:45  |  Presenter: Martin Johnston Phillips

      • Abstract

      No abstract available for this presentation

    • +

      ES08.03 - Evidence Based Evaluation of the Indeterminant Pulmonary Nodule

      16:45 - 16:57  |  Presenter: Annette McWilliams

      • Abstract

      No abstract available for this presentation

    • +

      ES08.04 - Biomarkers in the Evaluation of Pulmonary Nodule

      16:57 - 17:09  |  Presenter: James R Jett

      • Abstract

      Loading...

    • +

      ES08.05 - Targeting the SPN

      17:09 - 17:21  |  Presenter: Kwun Fong

      • Abstract

      No abstract available for this presentation

    • +

      ES08.06 - Bronchoscopic Treatment of SPN: Opportunities and Challenges

      17:21 - 17:33  |  Presenter: David Feller-Kopman

      • Abstract

      No abstract available for this presentation

    • +

      ES08.07 - Live Q&A

      17:33 - 17:45

      • Abstract

      No abstract available for this presentation

  • +

    MA04 - Health Policy and the Real World

    • 16:45 - 17:45
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Health Services Research/Health Economics
    • +

      MA04.01 - A Comparative Analysis of Lung Cancer Policies Across the Asia-Pacific Region

      16:45 - 16:50  |  Presenter: Rohini Omkar Prasad

      • Abstract

      Loading...

    • +

      MA04.02 - Lung Cancer Screening Utilization and Its Correlates in Sexual Minorities: An Analysis of the BRFSS 2018

      16:50 - 16:55  |  Presenter: Hui Xie

      • Abstract

      Loading...

    • +

      MA04.03 - Impact of Frailty Screening and Geriatrician-Led Comprehensive Geriatric Assessment in Frail Older Adults With Lung Cancer

      16:55 - 17:00  |  Presenter: Isabelle Lucy Rosemary Milner

      • Abstract

      Loading...

    • +

      MA04.04 - Assessing the Methodological Quality of Quality-of-Life Analyses in First-Line Lung Cancer Trials: A Systematic Review

      17:00 - 17:05  |  Presenter: Federico Daniel Waisberg

      • Abstract

      Loading...

    • +

      MA04.05 - Discussant

      17:05 - 17:15  |  Presenter: Pamela Samson

      • Abstract

      No abstract available for this presentation

    • +

      MA04.06 - Clinical Characteristics and Outcomes in Advanced KRAS Mutant NSCLC – A Multi-Centre Collaboration in Asia (ATORG-005)

      17:15 - 17:20  |  Presenter: Jiyun Lee

      • Abstract

      Loading...

    • +

      MA04.07 - Comparative Clinical Outcomes for Patients with NSCLC Harboring EGFR Exon 20 Insertion Mutations and Common EGFR Mutations

      17:20 - 17:25  |  Presenter: Nicolas Girard

      • Abstract

      Loading...

    • +

      MA04.08 - The Effect of Packed Red Blood Cell Transfusions on the Clinical Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients

      17:25 - 17:30  |  Presenter: Christopher Andrew D'Avella

      • Abstract

      Loading...

    • +

      MA04.09 - Impacts of Multidisciplinary Meeting Presentation: Drivers and Outcomes from a Population Registry Retrospective Cohort Study

      17:30 - 17:35  |  Presenter: Tiffany Lin

      • Abstract

      Loading...

    • +

      MA04.10 - Discussant

      17:35 - 17:45  |  Presenter: Mark Doherty

      • Abstract

      No abstract available for this presentation

  • +

    OA06 - Updates on EGFR Targeted Perioperative Therapy and Precision Adjuvant Chemotherapy

    • 16:45 - 17:45
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Early Stage/Localized Disease
    • +

      OA06.01 - Chair

      16:45 - 16:45  |  Presenter: Sun Min Lim

      • Abstract

      No abstract available for this presentation

    • +

      OA06.02 - Chair

      16:45 - 16:45  |  Presenter: Boris Sepesi

      • Abstract

      No abstract available for this presentation

    • +

      OA06.03 - Patient-Reported Outcomes from ADAURA: Osimertinib as Adjuvant Therapy in Patients with Resected EGFR Mutated (EGFRm) NSCLC

      16:45 - 16:55  |  Presenter: Margarita Majem

      • Abstract

      Loading...

    • +

      OA06.04 - Postoperative Chemotherapy Use and Outcomes from ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR Mutated NSCLC

      16:55 - 17:05  |  Presenter: Yi-long Wu

      • Abstract

      Loading...

    • +

      OA06.05 - Molecular and Clinical Features Associated with Relapse in Early Stage EGFR-Mutated NSCLC: A Single Institution Knowledge Bank

      17:05 - 17:15  |  Presenter: Stephanie Pei Li Saw

      • Abstract

      Loading...

    • +

      OA06.06 - Clinical/Biomarker Data for Neoadjuvant Atezolizumab in Resectable Stage IB-IIIB NSCLC: Primary Analysis in the LCMC3 Study

      17:15 - 17:25  |  Presenter: David Paul Carbone

      • Abstract

      Loading...

    • +

      OA06.07 - Discussant

      17:25 - 17:35  |  Presenter: Haiquan Chen

      • Abstract

      No abstract available for this presentation

    • +

      OA06.08 - Live Q&A

      17:35 - 17:45

      • Abstract

      No abstract available for this presentation

  • +

    PL03 - Bench to Bedside (Immunology) (Japanese, Mandarin, Spanish Translation Available)

    • 18:00 - 20:00
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL03.01 - Chair

      18:00 - 18:00  |  Presenter: Silvia Novello

      • Abstract

      No abstract available for this presentation

    • +

      PL03.02 - Chair

      18:00 - 18:00  |  Presenter: Benjamin Besse

      • Abstract

      No abstract available for this presentation

    • +

      PL03.03 - NSCLC and Immune Evasion: Insights from TRACERx

      18:00 - 18:20  |  Presenter: Charles Swanton

      • Abstract

      No abstract available for this presentation

    • +

      PL03.04 - Considering Biology of "Nodes" in Response to PD-1 Blockade in NSCLC

      18:20 - 18:40  |  Presenter: Matthew D Hellmann

      • Abstract

      No abstract available for this presentation

    • +

      PL03.05 - Cell Therapy for Solid Tumors

      18:40 - 19:00  |  Presenter: Prasad S Adusumilli

      • Abstract

      Loading...

    • +

      PL03.06 - Improving Outcomes with Immunotherapy: Lessons from Other Diseases

      19:00 - 19:20  |  Presenter: Carolyn Roberts

      • Abstract

      Loading...

    • +

      PL03.07 - Monitoring Disease Through Genomic/Immune Markers

      19:20 - 19:40  |  Presenter: Qing Zhou

      • Abstract

      No abstract available for this presentation

    • +

      PL03.08 - Live Q&A

      19:40 - 20:00

      • Abstract

      No abstract available for this presentation

  • +

    PS01 - Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)

    • 07:00 - 09:00
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PS01.14 - Chair

      07:00 - 07:00  |  Presenter: Tetsuya Mitsudomi

      • Abstract

      No abstract available for this presentation

    • +

      PS01.01 - Welcome Video

      07:00 - 07:02

      • Abstract

      No abstract available for this presentation

    • +

      PS01.02 - National Lung Cancer Screening Program in Taiwan: The TALENT Study

      07:02 - 07:12  |  Presenter: Pan-Chyr Yang

      • Abstract

      Loading...

    • +

      PS01.03 - Discussant

      07:12 - 07:20  |  Presenter: Ugo Pastorino

      • Abstract

      No abstract available for this presentation

    • +

      PS01.04 - International Tailored Chemotherapy Adjuvant Trial : ITACA Trial. Final Results

      07:20 - 07:30  |  Presenter: Silvia Novello

      • Abstract

      Loading...

    • +

      PS01.05 - Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary Analysis

      07:30 - 07:40  |  Presenter: Jay M. Lee

      • Abstract

      Loading...

    • +

      PS01.06 - Discussant

      07:40 - 07:50  |  Presenter: Shinichi Toyooka

      • Abstract

      No abstract available for this presentation

    • +

      PS01.07 - CodeBreaK 100: Registrational Phase 2 Trial of Sotorasib in KRAS p.G12C Mutated Non-small Cell Lung Cancer

      07:50 - 08:00  |  Presenter: Bob T. Li

      • Abstract

      Loading...

    • +

      PS01.08 - Discussant

      08:00 - 08:08  |  Presenter: Pasi Antero Jänne

      • Abstract

      No abstract available for this presentation

    • +

      PS01.09 - Pembrolizumab Plus Ipilimumab vs Pembrolizumab Plus Placebo as 1L Therapy for Metastatic NSCLC of PD-L1 TPS ≥50%: KEYNOTE-598

      08:08 - 08:18  |  Presenter: Michael Boyer

      • Abstract

      Loading...

    • +

      PS01.10 - Discussant

      08:18 - 08:26  |  Presenter: Yun Fan

      • Abstract

      No abstract available for this presentation

    • +

      PS01.11 - Nivolumab Versus Placebo in Relapsed Malignant Mesothelioma: The CONFIRM Phase 3 Trial

      08:26 - 08:36  |  Presenter: Dean Fennell

      • Abstract

      Loading...

    • +

      PS01.12 - Discussant

      08:36 - 08:44  |  Presenter: Rina Hui

      • Abstract

      No abstract available for this presentation

    • +

      PS01.13 - Live Q&A

      08:44 - 09:00

      • Abstract

      No abstract available for this presentation

  • +

    ES09 - Biomarkers in Immunotherapy

    • 09:15 - 10:15
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • +

      ES09.01 - Chair

      09:15 - 09:15  |  Presenter: Katerina Politi

      • Abstract

      No abstract available for this presentation

    • +

      ES09.02 - Chair

      09:15 - 09:15  |  Presenter: Melina Elpi Marmarelis

      • Abstract

      No abstract available for this presentation

    • +

      ES09.03 - Role of PD-L1 and Tumor Mutational Burden in NSCLC Immunotherapy

      09:15 - 09:25  |  Presenter: Solange Peters

      • Abstract

      Loading...

    • +

      ES09.04 - Individual Genomic Alterations as Predictive Factors for NSCLC Immunotherapy

      09:25 - 09:35  |  Presenter: Ferdinandos Skoulidis

      • Abstract

      No abstract available for this presentation

    • +

      ES09.05 - Blood-based Biomarkers for Immunotherapy: Applications and Limitations

      09:35 - 09:45  |  Presenter: Lizza Hendriks

      • Abstract

      Loading...

    • +

      ES09.06 - Immune Contexture and Immunotherapy Response in NSCLC

      09:45 - 09:55  |  Presenter: Kurt Alex Schalper

      • Abstract

      No abstract available for this presentation

    • +

      ES09.07 - Immunotherapy Biomarkers in NSCLC: Looking into the Future

      09:55 - 10:05  |  Presenter: Vamsidhar Velcheti

      • Abstract

      No abstract available for this presentation

    • +

      ES09.08 - Live Q&A

      10:05 - 10:15

      • Abstract

      No abstract available for this presentation

  • +

    ES10 - Advances in Lung Cancer Screening Through Imaging and Data Analytics

    • 09:15 - 10:15
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Screening and Early Detection
    • +

      ES10.01 - Chair

      09:15 - 09:15  |  Presenter: Charlene J Liew

      • Abstract

      No abstract available for this presentation

    • +

      ES10.02 - Chair

      09:15 - 09:15  |  Presenter: Yeol Kim

      • Abstract

      No abstract available for this presentation

    • +

      ES10.03 - AI-Enabled Lung Cancer Predictive Analytics - The Future of Lung Cancer Screening?

      09:15 - 09:27  |  Presenter: Zaiyi Liu

      • Abstract

      No abstract available for this presentation

    • +

      ES10.05 - Size Isn't Everything - Other High-Risk CT Imaging Features

      09:27 - 09:39  |  Presenter: Heber MacMahon

      • Abstract

      No abstract available for this presentation

    • +

      ES10.06 - Putting It Together: Current Best Practices in the Evaluation and Follow-Up of the Indeterminate Pulmonary Nodule

      09:39 - 09:51  |  Presenter: David Raymond Baldwin

      • Abstract

      Loading...

    • +

      ES10.07 - Live Q&A

      09:51 - 10:15

      • Abstract

      No abstract available for this presentation